GENE ONLINE|News &
Opinion
Blog

European Commission
GeneOnline’s Weekly News Highlights: Oct 8-Oct 13
2023-10-17
Recent Highlights of the RSV Vaccine Battle, with More Regulatory Approvals in Sight
2023-06-08
European Commission Continues Fight with Illumina and Orders Grail Acquisition Divestment
2022-12-07
The First Approved RSV Vaccine Worldwide Belongs to AstraZeneca and Sanofi
2022-11-06
Merck’s Streptococcus pneumoniae Expansion Finally Receives European Commission Approval
2022-10-24
Kite’s Yescarta Climbs Up To Treat Second-Line B-Cell Lymphomas After EC Nod
2022-10-18
AstraZeneca’s Rare Disease Treatment Wins Third Approval in European Union
2022-09-23
BridgeBio and Sentynl Therapeutics’ Nulibry Gets Greenlighted In Europe
2022-09-21
AstraZeneca’s Treatment for COVID-19 Wins European Approval
2022-09-20
Aurinia Wins Approval For Lupus Nephritis Therapy In Europe
2022-09-20
European Commission Prohibits Illumina’s Acquisition of GRAIL After The Company’s Win Against The FTC
2022-09-07
Novartis’ Treatment for Rare Cancer Wins European Commission’s Approval
2022-08-29
Johnson & Johnson’s Multiple Myeloma Treatment Wins Accelerated Approval
2022-08-24
Kyowa Kirin’s Treatment for a Rare Cancer Disorder Approved by European Commission
2022-08-19
CHMP Recommends Approval for Bristol Myers Squibb First-Line Treatment for Advanced Melanoma
2022-07-25
1 2
LATEST
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top